This inventor holds 1 USPTO granted patent. Top assignees: Cha University Industry-Academic Cooperation Foundation, Ewha University-Industry Collaboration Foundation, Yonsei University. Active years: 2025.
Company Filing History:
1 out of 8 
1 out of 204 
1 out of 1,470 
Years Active: 2025
Title: Seojeong Park: Innovator in Cancer Treatment
Introduction
Seojeong Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on developing compositions that can prevent, ameliorate, or treat cancer effectively.
Latest Patents
Seojeong Park holds 1 patent for his invention titled "Composition for prevention, amelioration, or treatment of cancer." This patent describes alpha-beta unsaturated aryl, heteroaryl, and cycloalkylene ketone compounds that are effective in inhibiting the growth of cancer cells and preventing metastasis to other tissues. His research highlights the potential of these compounds in cancer therapy.
Career Highlights
Throughout his career, Seojeong Park has been associated with prominent institutions such as Ewha University-Industry Collaboration Foundation and Cha University Industry-Academic Cooperation Foundation. His work in these organizations has allowed him to collaborate with other experts in the field and advance his research.
Collaborations
Seojeong Park has worked alongside talented individuals such as Youngjoo Kwon and Soo-Yeon Hwang. Their collaborative efforts have contributed to the development of innovative solutions in cancer treatment.
Conclusion
Seojeong Park's contributions to cancer research and treatment through his patent demonstrate his commitment to advancing medical science. His innovative approach has the potential to make a significant impact in the fight against cancer.